Abstract Details

Title Efficacy of Fremanezumab in Patients With Episodic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 110

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David B. Kudrow, MD (David Kudrow MD) PRESENTER	Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
	No disclosure on file
	No disclosure on file
Tricia Blankenbiller	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Ernesto Aycardi, MD (Kyowa Kirin)	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Marcelo E. Bigal, MD, PhD (Purdue)	No disclosure on file

��ɫ����